Mitopure Softgels Review

Mitopure Softgels by Timeline are one of the most recognizable urolithin A products on the market. This review judges them on the criteria that actually matter — dose, testing, format and value — rather than on hype, so you can decide whether softgels are the right way for you to reach a clinically studied dose.

Transparency note: SOMA HEALTH sells a competing urolithin A product, so treat this as a competitor's review and weigh it accordingly. We have kept the criteria brand-neutral and applied the same standard to ourselves.

What Mitopure Softgels are

Mitopure is Timeline's branded, high-purity urolithin A. The softgel is simply a convenient delivery format for that ingredient: a small capsule you swallow with water, taken daily. Timeline also sells urolithin A as a powder, but the softgel is the format most people mean when they say "Mitopure." Timeline is notable because it funded much of the early human research on urolithin A, so the brand has real scientific credibility behind it. That is worth acknowledging up front: this is not a fly-by-night product.

To understand what you are actually taking, it helps to know the ingredient. Urolithin A is a gut postbiotic. Your microbiome converts ellagitannins — compounds found in pomegranate, walnuts and certain berries — into urolithin A, but only some people convert efficiently, which is part of why a standardized supplement exists. Once absorbed, urolithin A supports mitophagy, the process by which cells recycle worn-out mitochondria. Our urolithin A guide and our explainer on what mitophagy is cover the biology in more depth.

Judging the softgels on four criteria

Dose

The most important question for any urolithin A product is whether the daily serving reaches the clinically studied range of roughly 500 to 1,000 mg per day. Mitopure's softgels are designed to deliver a full studied dose across a daily serving of two softgels, but exact milligrams per softgel and per serving can change, so check the current label before you buy. The principle to hold onto is simple: confirm the total daily amount, not the amount in a single softgel. A product that only reaches a fraction of the studied dose will not match what the trials tested.

Testing and quality

Urolithin A is a manufactured, high-purity ingredient, and Timeline has built its reputation partly on quality control and published research. That is a genuine strength. When you evaluate any urolithin A product, including this one, look for clear statements about purity and independent verification. Mitopure scores well on the credibility of its science and manufacturing.

Format: the softgel trade-off

Softgels are the crux of this review. For people who are comfortable swallowing capsules, a softgel is compact, tasteless and easy. But softgels have real downsides for some users: people who dislike or struggle to swallow pills, and those who tend to forget a daily capsule, may not stick with the routine. Because urolithin A only helps when taken consistently, format is not a cosmetic detail — it directly affects whether you reach the studied dose day after day. If you already take capsules happily, this is a non-issue. If you do not, it is the single biggest reason to consider an alternative format such as a gummy or powder.

Value

Judge value by the monthly cost of reaching a full studied daily dose, not the sticker price of a bottle. We will not quote Mitopure's price because it varies by retailer, subscription and promotion — check the current label and listing. The useful exercise is to divide the price by the number of full studied daily doses in the package and compare that number across products.

What the human evidence says the softgels can support

Because the active ingredient is urolithin A, the evidence for Mitopure Softgels is the evidence for the molecule at a studied dose. The strongest human data is in muscle. Andreux et al. 2019 (Nature Metabolism), the first-in-human trial, found urolithin A was safe and well tolerated at doses up to 1,000 mg per day and produced a mitochondrial gene-expression signature in participants. Singh et al. 2022 (Cell Reports Medicine) tested 500 mg and 1,000 mg arms in middle-aged adults over four months and reported improvements in muscle strength and exercise performance. Liu and D'Amico et al. 2022 (JAMA Network Open) studied older adults over about four months and found gains in muscle endurance, measured as the number of muscle contractions before fatigue.

Newer human trials are broadening the picture. A 2024 randomized trial in the Journal of the International Society of Sports Nutrition examined endurance and recovery markers in resistance-trained men over eight weeks, and a 2025 randomized trial in Nature Aging reported support for immune-cell mitochondrial health in midlife adults over roughly 28 days, in the context of age-related low-grade inflammation. Taken together, the fair reading — echoed by a 2024 systematic review in Ageing Research Reviews — is that the human evidence is genuinely promising but still emerging, built on relatively short trials with modest sample sizes.

Much of the excitement around urolithin A also comes from preclinical work, which should be labeled as such. Ryu et al. 2016 (Nature Medicine) is the foundational study: it established mitophagy, extended lifespan in the worm C. elegans and improved muscle function in rodents — animal and cell data, not human proof. D'Amico et al. 2022 (Aging Cell) explored joint and cartilage mitochondrial health in osteoarthritis models, again in animals. Areas such as skin, gut, brain and heart health remain at the early or preclinical stage, where research is exploring possibilities rather than demonstrating human outcomes. Urolithin A supports muscle and mitochondrial health; it is not a treatment for any disease, and this is not a treatment claim — if you have a health condition, see your doctor before starting. For more, see our urolithin A clinical studies page and the roundup of the best urolithin A gummies.

Who Mitopure Softgels are a good fit for

Mitopure Softgels make the most sense for someone who values Timeline's research pedigree, is perfectly comfortable swallowing a daily capsule, and wants a well-established brand. They are a solid, credible product. The people who should think twice are those who dislike pills, tend to skip daily capsules, or are optimizing purely for value per studied dose — for them, a gummy or powder that reaches the same studied range can be a better practical match. The molecule is the same; the deciding factors are format, adherence and cost.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.